EP Patent

EP2500014B2 — Slow release pharmaceutical composition made of microparticles

Assigned to Debiopharm International SA · Expires 2025-02-19 · 1y expired

What this patent protects

Patent listed against triptorelin-pamoate.

Drugs covered by this patent

triptorelin-pamoate (TRIPTORELIN PAMOATE)

Patent Metadata

Patent number: EP2500014B2
Jurisdiction: EP
Classification: —
Expires: 2025-02-19
Drug substance claim: No
Drug product claim: No
Assignee: Debiopharm International SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.